Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0W4QB
|
||||
Former ID |
DIB016903
|
||||
Drug Name |
EPI-12323 combination therapy
|
||||
Synonyms |
EPI-12323 combination therapy (asthma/ COPD); EPI-12323 combination therapy (asthma/ COPD), EpiGenesis; EPI-12323 + beta agonist (asthma/COPD), EpiGenesis
|
||||
Indication | Asthma; Chronic obstructive pulmonary disease [ICD9: 490-492, 493, 494-496; ICD10:J40-J44, J47, J45] | Phase 1 | [547408] | ||
Company |
EpiGenesis Pharmaceuticals Inc
|
||||
Target and Pathway | |||||
Target(s) | Beta-3 adrenergic receptor | Target Info | Agonist | [543746] | |
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.